Sign In
Buy ABEO
$6.42
-0.0500 (-0.773%)
At Close: Jul 31, 2026
Can Vertex (VRTX) Withstand the Coronavirus Impact on Q1 Earnings?
03:39pm, Friday, 24'th Apr 2020
On Vertex's (VRTX) first-quarter earnings call, investor focus will be on the sales uptake of its newly-launched CF drug, Trikafta.
Can Vertex (VRTX) Withstand the Coronavirus Impact on Q1 Earnings?
03:39pm, Friday, 24'th Apr 2020
On Vertex's (VRTX) first-quarter earnings call, investor focus will be on the sales uptake of its newly-launched CF drug, Trikafta.
Is a Beat in Store for Abeona (ABEO) This Earnings Season?
02:35pm, Friday, 24'th Apr 2020
Abeona's (ABEO) operating expenses are expected to have increased in the first quarter driven by clinical studies on its lead gene therapy candidate.
Abeona Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
08:04pm, Tuesday, 21'st Apr 2020
Abeona Therapeutics Inc. (ABEO), a fully-integrated leader in gene and cell therapy, today announced it granted options to Brian Pereira, M.D., the newly-appointed Executive Chairman of the Company, t
Abeona Therapeutics Appoints Brian Pereira and Shawn Tomasello to the Board of Directors
12:00pm, Tuesday, 21'st Apr 2020
NEW YORK and CLEVELAND, April 21, 2020 -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced appointments of Brian.
Implied Volatility Surging for Abeona Therapeutics (ABEO) Stock Options
12:43pm, Monday, 20'th Apr 2020
Investors need to pay close attention to Abeona Therapeutics (ABEO) stock based on the movements in the options market lately.
Investors Who Bought Abeona Therapeutics (NASDAQ:ABEO) Shares A Year Ago Are Now Down 71%
10:06am, Monday, 20'th Apr 2020
The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy. But...
Dynavax Technologies (DVAX) in Focus: Stock Moves 9.1% Higher
12:44pm, Friday, 17'th Apr 2020
Dynavax Technologies (DVAX) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Dynavax Technologies (DVAX) in Focus: Stock Moves 9.1% Higher
12:44pm, Friday, 17'th Apr 2020
Dynavax Technologies (DVAX) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
NEW YORK, April 17, 2020 -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Abeona Therapeutics.
Axsome's AXS-07 Meets Co-Primary Goals in Migraine Study
04:37pm, Tuesday, 07'th Apr 2020
Axsome's (AXSM) AXS-07 achieves both regulatory co-primary endpoints in the phase III INTERCEPT study for the early treatment of migraine.
Mallinckrodt Starts Rolling BLA Filing for StrataGraft Tissue
03:14pm, Tuesday, 07'th Apr 2020
Mallinckrodt (MNK) begins rolling submission of BLA for StrataGraft regenerative skin tissue therapy to the FDA for addressing adult patients with deep partial-thickness thermal burns. Stock rises.
Mallinckrodt Starts Rolling BLA Filing for StrataGraft Tissue
03:14pm, Tuesday, 07'th Apr 2020
Mallinckrodt (MNK) begins rolling submission of BLA for StrataGraft regenerative skin tissue therapy to the FDA for addressing adult patients with deep partial-thickness thermal burns. Stock rises.
Edited Transcript of ABEO earnings conference call or presentation 17-Mar-20 2:00pm GMT
08:12am, Sunday, 05'th Apr 2020
Q4 2019 Abeona Therapeutics Inc Earnings Call
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Abeona Therapeutics (ABEO), Teva Pharmaceutical Industries (TEVA) and
